Insulet campaign takes aim at workplace challenges for people with diabetes

Madrigal CEO welcomes MASH competition from Novo as demand climbs higher for Rezdiffra

Madrigal Pharmaceuticals CEO Bill Sibold doesn’t seem worried about sharing the MASH market with Novo Nordisk’s blockbuster GLP-1 drug. In an interview with Endpoints News

What health tech stands to gain as pharma goes DTC

When the Trump administration in September debuted TrumpRx.gov as part of its deal with Pfizer at “most favored nation” prices, my mind immediately turned to

Bidding war breaks out as Novo raises Metsera bid to $10bn

Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.

Incyte, Prelude ink rare blood cancer pact; Merck takes back rights to Prometheus asset

Plus, news about Kaigene, Celltrion, Solid Bio, Terns Pharmaceuticals, Benitec, Pacira, AmacaThera, UCB, Basilea Pharmaceutica, Pfizer, Kura Oncology, Kyowa Kirin, Novavax, Sanofi, Syndexis and Relmada:

Lilly and Novo near White House deal on obesity drug prices

Eli Lilly and Novo Nordisk are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs, in